Transfusion service staff and anesthesiologists prefer pathogen‐reduced cryoprecipitate over conventional cryoprecipitated antihemophilic factor

Documenti analoghi

• Implementation of pathogen reduced cryoprecipitate for surgical services: A retrospective review of blood product utilization and fibrinogen repletion
  di: Joshua Nicholas, et al.
  Pubblicazione: (2025)
• Pathogen‐reduced plasma, cryoprecipitate reduced for therapeutic plasma exchange
  di: Florian Tupin, et al.
  Pubblicazione: (2026)
• Pathogen‐reduced cryoprecipitate: Early experiences and inventory management
  di: C. B. Webb, et al.
  Pubblicazione: (2025)
• Retention of critical platelet hemostatic functions of amotosalen‐ UVA pathogen‐reduced cryoprecipitated fibrinogen complex
  di: Florian Tupin, et al.
  Pubblicazione: (2026)
• The clinical use of cryoprecipitate and fibrinogen concentrate: A scoping review
  di: Aaron S. Hess, et al.
  Pubblicazione: (2026)